American Vanguard Q3 2026 earnings

AVD · 2026-11-10 16:01 AMC ET · 8-K on SEC

Adjusted EBITDA turned negative in Q3 despite revenue decline, driven by negative operating leverage and higher costs.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$108.4M-9.0%—Ex. 99.1, income statement
EPS (GAAP)-$0.61——Ex. 99.1, income statement
Net income-$17.7M——Ex. 99.1, income statement
Adj. EBITDA-$24K——Ex. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
U.S. Crop$42.3M-2.0%39%Q3 only
U.S. Specialty$18.9M-2.0%17%Q3 only
Total U.S.$61.2M-2.0%56%Q3 only
International$47.2M-17.0%44%Q3 only
Total net sales$108.4M-9.0%100%Q3 only

Margins and costs

  • Gross margin 24.0% (prior 31%, change -7.0 pp)
  • Operating expenses -$32,826 (+3% YoY)
  • One-offs in the quarter CFO transition costs $1.3M; Product liability claims $22K; Asset impairments $0; Other $12K
  • Effective tax rate 3.2% (prior-year 3.5%, year-to-date 3.3%)
  • Non-GAAP bridge Adds back stock compensation, transformation costs, product liability claims, asset impairments, and other items; excludes amortization of intangibles from Adjusted operating expenses.

KPIs

MetricActualPrior quarterPrior yearChange
Net trade working capital$22M——+14%
Customer prepayments$44.6M——+44%
Capital expenditures$4.7M———

Guidance

not stated in the 8-K

What drove it

  • Revenue story Total sales fell 9% YoY to $108.4M; U.S. sales declined 2% while International sales dropped 17% YoY.
  • EPS story Net loss widened to -$0.61 per share from -$0.43 YoY, driven by lower revenue, higher costs, and negative operating leverage.
  • One-off check CFO transition costs of $1.3M and product liability claims of $22K are one-time items.

The good

  • U.S. market outperformance
  • Customer prepayments up 44%
  • Net trade working capital improved 14% YoY
  • Adjusted operating expenses down 3% YoY

The bad

  • Adjusted EBITDA turned negative (-$24K)
  • Gross margin compressed to 24%
  • International sales down 17% YoY
  • Operating loss widened to -$7.97M

The ugly

  • none

Open questions

  • How will the company recover gross margins given the sharp rise in diesel and transportation costs?
  • What is the timeline for realizing the $4M annualized savings from the L.A. plant rationalization?
Full release

American Vanguard (AVD) earnings release, November 10, 2026

American Vanguard Corp (AVD) · Form 8-K, Item 2.02 · Filed · SEC filing

American Vanguard Reports Third Quarter 2026 Results

Strategic Deals in Quarter Expand U.S. Product Portfolio

Consolidation Driving Manufacturing Efficiency Gains

El Nino and Geopolitics Pressure Global Agricultural Markets

Irvine, CA | November 9, 2026 — American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the third quarter and nine-months ended September 30, 2026.

Third Quarter 2026 Financial and Operational Highlights – versus Third Quarter 2025

Dak Kaye, CEO of American Vanguard, stated, “Our actions are taking hold, and the progress we are making across

American Vanguard continues to build, even as market conditions remain difficult, particularly outside the U.S., where El Niño is materially impacting our business this year. In the U.S., our largest and most important market, we continue to outperform our peers in a challenging environment. The cost actions we took in the first half, including the rationalization of our Los Angeles facility and the relocation of our headquarters are beginning to deliver operational savings. In the near term, however, those savings have been more than offset by a sharp rise in diesel and other transportation costs arising from instability in the Middle East. We are working to recover gross margins through commercial actions.”

Mr. Kaye continued, “Importantly, we are building a new product engine that we believe will drive growth over the next several years. At the end of the third quarter, we acquired four U.S. brands and registrations from Syngenta® and entered into a distribution agreement with Sipcam Agro, which together meaningfully expand our portfolio.

Combined with our pipeline of new product launches, these additions support our goal of driving $100 million in annualized revenue from new products by 2030. I am also pleased that we have further strengthened our leadership team in the quarter with the additions of Matt Horwath as Chief Financial Officer, and Hermann Castro, Senior Vice President of Marketing and Business Development, to drive new product development and Mark Helt as President of U.S. Crop. Our focus is the same in every market: stay close to our customers, provide service and solutions, and control what we can control.”¹

Matt Horwath, Chief Financial Officer, stated, “We began to see progress this quarter in terms of lower operating costs and improved manufacturing efficiencies as a result of actions taken earlier this year. However, this progress was more than offset in the quarter by the effects of negative operating leverage, driven by lower international sales and higher raw material and transportation costs. Net trade working capital improved by $22 million, or 14%, versus the prior year period. Higher pre-payments in the quarter, which increase by 44% year-over-year, demonstrate customer confidence and bode well for revenue in the 2027 planting season.”

Earnings Conference Call

The company will be hosting an earnings conference call on November 9, 2026 at 5:00 pm Eastern Time/2:00 pm Pacific Time.

The conference call will be webcast on the Company’s website at https://www.investors-american vanguard.com

/ or by going to the following link: https://www.webcaster5.com/Webcast/Page/3070/54771

If you are unable to listen live, the conference call will be archived for one year and may be accessed using the company’s website: https://www.investors-american-vanguard.com/

About American Vanguard

American Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference www.american-vanguard.com.

Financial statements

Income Statement

For the Three Months Ended September 30, — (Unaudited) (in thousands)

For the Three Months Ended September 30, – 2026For the Three Months Ended September 30, – 2025For the Nine Months Ended September 30, – 2026For the Nine Months Ended September 30, – 2025
Net sales108,376119,313348,698364,426
Cost of sales-82,124-85,099-249,316-259,474
Gross profit26,25234,21499,382104,952
Operating expenses
Selling, general and administrative-25,797-26,747-80,133-81,998
Research, product development and regulatory-5,342-5,654-17,097-17,139
Product liability claims-22-7,029-223-7,029
CFO transition costs-1,316-1,316
Transformation-1,665-1,442-5,975-5,254
Asset impairments-93-943-227
(Loss) gain from sale of assets-75246-75246
Operating loss-7,965-6,505-6,380-6,449
Change in fair value of an equity investment-21-511-193-511
Interest expense, net-9,146-4,920-24,066-13,135
Loss before provision for income taxes-17,132-11,936-30,639-20,095
Income tax expense-536-422-1,043-1,574
Net loss-17,668-12,358-31,682-21,669
Net loss per common share—basic-0.61-0.43-1.1-0.76
Net loss per common share—assuming dilution-0.61-0.43-1.1-0.76
Weighted average shares outstanding—basic28,77528,51128,69128,377
Weighted average shares outstanding—assuming dilution28,77528,51128,69128,377

Income Statement

For the Three Months Ended September 30, — (Unaudited) (in thousands)

For the Three Months Ended September 30, – 2026For the Nine Months Ended September 30, – 2026For the Three Months Ended September 30, – 2025For the Nine Months Ended September 30, – 2025Change% Change
Net sales:
U.S. Crop42,31643,310-994-2.0%
U.S. Specialty18,87219,233-361-2.0%
Total U.S.61,18862,543-1,355-2.0%
International47,18856,770-9,582-17.0%
Total net sales108,376119,313-10,937-9.0%
Total cost of sales-82,124-85,0992,975-3.0%
Total gross profit26,25234,214-7,962-23.0%
Total gross margin24.0%29
U.S. Crop157,510153,5113,9993.0%
U.S. Specialty57,04554,0672,9786.0%
Total U.S.214,555207,5786,9773.0%
International134,143156,848-22,705-14.0%
Total net sales348,698364,426-15,728-4.0%
Total cost of sales-249,316-259,47410,158-4.0%
Total gross profit99,382104,952-5,570-5.0%
Total gross margin29.0%29

Income Statement

For the Three Months Ended September 30, — (Unaudited) (in thousands)

For the Three Months Ended September 30, – 2026For the Three Months Ended September 30, – 2025For the Nine Months Ended September 30, – 2026For the Nine Months Ended September 30, – 2025
Net loss-17,668-12,358-31,682-21,669
Provision for income taxes5364221,0431,574
Interest expense, net9,1464,92024,06613,135
Depreciation and amortization4,6204,56513,86114,023
Stock compensation expense3277609011,741
CFO transition costs1,3161,316
Transformation costs1,6651,4425,9755,254
Product liability claims & related expenses227,6102237,610
Asset impairments801943935
Other1248203-381
Adjusted EBITDA(1)-248,21016,84922,222

Balance Sheet

September 30, 2026 — (In thousands, except share data) (Unaudited)

September 30, 2026December 31, 2025
Current assets:
Cash83,90912,425
Receivables:
Trade, net of allowance for credit losses of $14,336 and $11,733, respectively142,677160,511
Other7,5227,278
Total receivables, net150,199167,789
Inventories194,079176,034
Prepaid expenses8,4649,668
Income taxes receivable1,7504,606
Total current assets438,401370,522
Property, plant and equipment, net51,95653,036
Operating lease right-of-use assets, net16,40716,793
Intangible assets, net139,809138,746
Deferred income tax assets2,9632,637
Other assets13,87414,803
Total assets663,410596,537
Current liabilities:
Accounts payable86,32587,505
Customer prepayments44,62133,094
Accrued program costs46,82552,227
Accrued expenses and other payables26,70428,261
Current portion of long-term debt3,750
Operating lease liabilities, current5,6375,765
Income taxes payable3,3702,594
Total current liabilities217,232209,446
Long-term debt, net of current portion263,937174,000
Operating lease liabilities, long-term11,24311,621
Deferred income tax liabilities7,1158,150
Other liabilities760923
Total liabilities500,287404,140

Cash Flow

For the Nine Months Ended September 30, — (Unaudited) (in thousands)

For the Nine Months Ended September 30, – 2026For the Nine Months Ended September 30, – 2025
Cash flows from operating activities:
Net loss-31,682-21,669
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of property, plant and equipment and intangible assets13,44214,007
Amortization of other long-term assets516
Loss (gain) on disposal of property, plant and equipment75-246
Provision for estimated credit losses2,4691,944
Stock-based compensation9011,741
Deferred income taxes-1,073-353
Change in liabilities for uncertain tax positions or unrecognized tax benefits-127-522
Change in equity investment fair value193511
Impairment of assets943227
Payment-in-kind debt leverage fee1,261
Amortization of deferred loan fees2,8991,167
Lease obligations and non-cash lease expense, net-120-150
Unrealized foreign currency transaction losses (gains)243-704
Changes in assets and liabilities associated with operations:
Decrease in net receivables14,812935
Increase in inventories-16,007-16,513
Increase in prepaid expenses and other assets-1,039-965
Change in income tax receivable and payable, net3,526-1,083
(Decrease) increase in accounts payable-96011,859
Increase (decrease) in customer prepayments11,527-21,453
(Decrease) increase in accrued program costs-5,45412,285
Decrease in other payables and accrued expenses-8,180-8,178
Net cash used in operating activities-12,346-27,144
Cash flows from investing activities:
Capital expenditures-4,676-2,398
Proceeds from disposal of property, plant and equipment10492
Intangible assets-5,149-136
Net cash used in investing activities-9,815-2,042
Cash flows from financing activities:
Payments under line of credit agreement-140,000-179,415
Borrowings under line of credit agreement26,000214,334
Borrowings under term loans225,000
Repayments of term loans-1,125
Payment of deferred loan fees-16,581-3,339
Net receipt from the issuance of common stock under ESPP474629
Net payment from common stock purchased for tax withholding-99-147
Net cash provided by financing activities93,66932,062
Net increase in cash71,5082,876
Effect of exchange rate changes on cash and cash equivalents-241,405
Cash at beginning of period12,42512,514
Cash at end of period83,90916,795

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts.

Forward looking statements often use words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “outlook,” “forecast,”

“target,” “trend,” “plan,” “goal,” or other words of comparable meaning or future-tense or conditional verbs such as “may,” “will,” “should,” “would,” or

“could.” These forward-looking statements are based on the current expectations and estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include risks detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements.²

Non-GAAP

Financial Measures

In addition to providing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), we present Adjusted EBITDA and Adjusted operating expenses, which are non-GAAP financial measures. These measures should not be considered in isolation or as an alternative to GAAP measures such as net income, or diluted earnings per share, as applicable, or other financial statement data presented in our financial statements as an indicator of our financial performance or liquidity.... (truncaITDA as net (loss) income, adjusted for depreciation and amortization, provision for income taxes and interest expense. We define Adjusted EBITDA as EBITDA as further adjusted for stock compensation expense and for certain items management believe are not reflective of the underlying operations of our business, including but not limited to the exclusion of charges that are considered by management to be unusual and not representative of the Company’s underlying performance and future prospects. In 2026 and 2025 that included non-recurring expenses. The resulting Adjusted EBITDA measure is aligned with the Company’s metric for its credit facility agreement in the applicable periods.

We define Adjusted operating expense as operating expenses as further adjusted for stock compensation expense and for certain items management believe are not reflective of the underlying operations of our business, including but not limited to the exclusion of charges that are considered by management to be unusual and not representative of the Company’s underlying performance and future prospects as well as the amortization expense for intangibles assets related to acquired product lines.

We use Adjusted EBITDA and Adjusted operating expenses to assess the operating results and effectiveness and efficiency of our business. We present this non-GAAP financial measure because we believe that investors consider Adjusted EBITDA and Adjusted operating expenses to be an important supplemental measure of performance, and we believe that this measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. As the Company continues to work through its transformation efforts, management believes that presenting Adjusted EBITDA and Adjusted operating expenses provides an effective comparison between the Company and its industry peers.

Non-GAAP financial measures as reported by us may not be comparable to similarly titled metrics reported by other companies and may not be calculated in the same manner. These measures have limitations as analytical tools, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP.

The Company is not able to provide a reconciliation without unreasonable efforts of its forward-looking guidance related to Adjusted EBITDA and Adjusted operating expenses to the most directly comparable GAAP financial measure due to the inherent difficulty in predicting with reasonable certainty the timing and amount of certain items that are excluded from Adjusted EBITDA and Adjusted operating expenses, such as share-based compensation, acquisition-related expenses, and foreign exchange gains or losses, which could be material to the Company’s results computed in accordance with GAAP.

Investor Representative

Alpha IR Group

Robert Winters

Robert.winters@alpha-ir.com

(917)

821-6305

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · American Vanguard earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.